These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7860668

  • 1. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
    Katsuta K, Nakanishi H, Shirakawa K, Yoshida K, Takagi K, Tamura A.
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):345-8. PubMed ID: 7860668
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY, Sun CK, Xiao XW, Lin YZ, Li S, Ma H, Song GR, Cheng R.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2479-84. PubMed ID: 17156678
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
    Sharkey J, Ritchie IM, Butcher SP, Kelly JS.
    Brain Res; 1996 Sep 30; 735(1):67-82. PubMed ID: 8905171
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [NMDA receptor antagonists in focal cerebral ischemia. An experimental model].
    Nathal E, Miquelajauregui JM, Herreman F, Alvarado R, Romero V, Mateos Gomez JH.
    Gac Med Mex; 1993 Sep 30; 129(2):125-30. PubMed ID: 7926393
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Systemic hyperthermia masks the neuroprotective effects of MK-801, but not rosiglitazone in brain ischaemia.
    Nategh M, Shaveisi K, Shabanzadeh AP, Sadr SSh, Parviz M, Ghabaei M.
    Basic Clin Pharmacol Toxicol; 2010 Sep 30; 107(3):724-9. PubMed ID: 20406202
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats.
    Esneault E, Castagne V, Moser P, Bonny C, Bernaudin M.
    Neuroscience; 2008 Mar 18; 152(2):308-20. PubMed ID: 18262367
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protective effect of FR115427 against ischemic hippocampal damage in gerbils.
    Nakanishi H, Katsuta K, Koide T, Ueda Y, Shirakawa K, Yoshida K.
    Jpn J Pharmacol; 1994 Mar 18; 64(3):189-93. PubMed ID: 8022120
    [Abstract] [Full Text] [Related]

  • 18. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
    Dawson DA, Graham DI, McCulloch J, Macrae IM.
    Br J Pharmacol; 1994 Sep 18; 113(1):247-53. PubMed ID: 7529111
    [Abstract] [Full Text] [Related]

  • 19. Endothelin-1-induced cerebral ischemia: effects of ketanserin and MK-801 on limb placing in rats.
    Moyanova S, Kortenska L, Mitreva R.
    Int J Neurosci; 2007 Sep 18; 117(9):1361-81. PubMed ID: 17654097
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
    Takaoka S, Bart RD, Pearlstein R, Brinkhous A, Warner DS.
    J Cereb Blood Flow Metab; 1997 Feb 18; 17(2):161-7. PubMed ID: 9040495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.